Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunction

Heart Rhythm

Volumn 5, Issue 4, 2008, Pages 507-510

  Coleman, Craig I ^a,b   Kluger, Jeffrey ^a,b   Bhavnani, Sanjeev ^a   Clyne, Christopher ^a,b   Yarlagadda, Ravi ^a   Guertin, Danette ^a   White, C Michael ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Implantable cardioverter defibrillator; Left ventricular systolic dysfunction; Mortality; Statins; Ventricular arrhythmia

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOFETILIDE; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; SOTALOL; WARFARIN;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DRUG FATALITY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION; TEACHING HOSPITAL; UNITED STATES; URBAN AREA;

AGED; ANTI-ARRHYTHMIA AGENTS; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE; SYSTOLE; TACHYCARDIA, VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FIBRILLATION;

EID: 40849133896     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.12.023     Document Type: Article

References (7)

1. Mitchell L.B., Powell J.L., Gillis A.M., and AVID Investigators. Are lipid-lowering drugs also antiarrhythmic drugs?. J Am Coll Cardiol 42 (2003) 81-87
2. Goldberger J.J., Subacius H., Schaechter, and DEFINITE Investigators. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1228-1233
3. Kadish A., Dyer A., Daubert J.P., and DEFINITE Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
4. Vyas A.K., Guo H., Moss A.J., and MADIT-II Research Group. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II. J Am Coll Cardiol 47 (2006) 769-773
5. Dickinson M.G., Ip J.H., Olshansky B., and SCD-HeFT Investigators. Am Heart J 153 (2007) 573-578
6. Kjekshus J. Debate: statins should be used in patients with heart failure. Curr Control Trials Cardiovasc Med 2 (2001) 268-270
7. White C.M. Pharmacologic effects of HMG CoA Reductase inhibitors other than lipid modulation. J Clin Pharmacol 39 (1999) 111-118